Vilnius proved to be an exceptionally attractive location in terms of available qualified talent. The multilingualism of the local talent pool was one of the strongest selling points for us, as fluency and language competencies are crucial in serving our customers from all around the world.
Dexcom, Inc., (NASDAQ:DXCM), the global leader in continuous glucose monitoring (CGM) for people with diabetes, has announced opening a global business services (GBS) centre in Vilnius, Lithuania. The new hub is set to open its doors in 2021 and will expand the company’s patient support, customer advocacy and finance and accounting operations in Europe.
The San Diego-based medical device manufacturer will be joining the booming GBS community of Vilnius. Currently, the city is home to more than 80 centres, including those operated by numerous Fortune 500 companies. Lithuania’s capital was picked after a diligent selection process, which involved sorting through a long list of locations throughout central-eastern Europe.
“Vilnius proved to be an exceptionally attractive location in terms of available qualified talent. The multilingualism of the local talent pool was one of the strongest selling points for us, as fluency and language competencies are crucial in serving our customers from all around the world,” said Quentin Blackford, executive vice president, chief operating officer and chief financial officer at Dexcom. “We were also impressed by the excellent support provided by Invest Lithuania, who quickly became a valuable partner for the project.”
The Vilnius office will support Dexcom operations and its customers across the EMEA region. The new branch is set to be multifaceted and will focus on customer and technical support related to Dexcom products and on providing finance and accounting support for the organization, including accounts receivable, accounts payable, payroll, billing and more.
“The decision by Dexcom to locate its new GBS centre for the EMEA region in Lithuania marks another victory for our medical devices sector,” said Remigijus Sinkevičius, Lithuania’s minister of economy and innovation. “It also serves as proof of the quality of local talent available to the growing global business services community. I believe that Dexcom will feel right at home here.”
Dexcom is implementing robotic process automation (RPA) in its new centre as part the service offering across EMEA. There are also plans to collaborate with local universities and other educational institutions.
“Lithuania sees life sciences as one of the most crucial sectors of the future. The arrival of an industry player of such importance will help us – as a country – to further develop the competencies necessary to excel in this field,” said Mantas Katinas, general manager of Invest Lithuania.
About the company
Founded in 1999, Dexcom empowers people to take control of their diabetes through innovative continuous glucose monitoring systems. By listening to the needs of users, caregivers and healthcare providers, Dexcom simplifies and improves diabetes management around the world. As of 2019, the company employed 3,900 specialists across multiple locations worldwide. The company’s total revenue for 2019 was $1.470 billion. Visit the official website to see the company’s job listings.
Subscribe to our newsletter!
Don't miss out on all the latest news on the Lithuanian business environment